August 16, 2026 at 07:33 AM 2 min readindiadeveloping
FDA Notice to Shah Rukh Khan and Ajay Devgn Over Vimal Elaichi Ads
FDA Crackdown on Celebrity Endorsements:
The Food and Drug Administration (FDA) of Maharashtra, led by Commissioner Tukaram Mundhe, has issued formal show-cause notices to Bollywood superstars Shah Rukh Khan, Ajay Devgn, and Tiger Shroff. The notices demand an explanation regarding their participation in advertisements for "Vimal Elaichi," a brand often associated with gutka and tobacco products through surrogate advertising. The actors have been given a strict 15-day deadline to respond and justify their endorsement of products that public health advocates argue promote harmful substances. This move marks a significant escalation in the regulatory oversight of celebrity brand partnerships in India.
Background of Advertising Backlash:
The controversy surrounding Vimal advertisements is not new, as the brand has long been criticized for using "elaichi" (cardamom) as a front for its tobacco-based portfolio. Previously, actor Akshay Kumar faced massive social media backlash for joining the brand's campaign, leading him to publicly apologize and announce his withdrawal from the endorsement. However, Shah Rukh Khan and Ajay Devgn have continued their association despite recurring public health campaigns. The FDA’s intervention now brings legal weight to these moral arguments, focusing on whether these advertisements violate existing tobacco control laws that prohibit the direct or indirect promotion of tobacco products.
Implications for Brand Endorsements in India:
The outcome of this notice could redefine the landscape for celebrity endorsements in the consumer goods sector. If the FDA finds the explanations unsatisfactory, the actors could face fines or be barred from such campaigns under the Cigarettes and Other Tobacco Products Act (COTPA). For the average Indian reader, this development signals a stronger governmental stance on public health and corporate accountability. The single most important signal to watch for next is whether other state FDAs follow Maharashtra’s lead or if the central government introduces stricter guidelines for surrogate marketing on national television and digital platforms.
Pulse Intelligence
Context & ImpactContext & Background
- Surrogate advertising is a practice where brands promote products like alcohol or tobacco by using similar branding for non-prohibited items like water, soda, or elaichi.
- Akshay Kumar exited the 'Vimal Universe' in 2022 after fans called out the hypocrisy of a fitness icon promoting a tobacco-affiliated brand.
Key Consequences
- The actors may be forced to terminate their existing contracts with Vimal to avoid legal penalties and reputational damage.
- National advertising standards may be revised to specifically ban 'color-matched' or 'logo-matched' surrogate ads during prime-time slots.
Market & Economic Impact
Potential impact on the advertising revenue of major television networks and the market valuation of large tobacco companies using surrogate marketing.
The Indus Pulse is committed to accuracy and transparency.